In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Recombinant Vaccine in these regions, from 2013 to 2025 (forecast).
United States Recombinant Vaccine market competition by top manufacturers/players, with Recombinant Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck & Co., Inc.
Green Cross Corporation
Pfizer, Inc.
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc
Novartis AG
Bharat Biotech
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Human
Animal
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Recombinant Vaccine Market Report 2018
1 Recombinant Vaccine Overview
1.1 Product Overview and Scope of Recombinant Vaccine
1.2 Classification of Recombinant Vaccine by Product Category
1.2.1 United States Recombinant Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Recombinant Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Subunit Recombinant Vaccines
1.2.4 Attenuated Recombinant Vaccines
1.2.5 Vector Recombinant Vaccines
1.3 United States Recombinant Vaccine Market by Application/End Users
1.3.1 United States Recombinant Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Human
1.3.3 Animal
1.4 United States Recombinant Vaccine Market by Region
1.4.1 United States Recombinant Vaccine Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Recombinant Vaccine Status and Prospect (2013-2025)
1.4.3 Southwest Recombinant Vaccine Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Recombinant Vaccine Status and Prospect (2013-2025)
1.4.5 New England Recombinant Vaccine Status and Prospect (2013-2025)
1.4.6 The South Recombinant Vaccine Status and Prospect (2013-2025)
1.4.7 The Midwest Recombinant Vaccine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Recombinant Vaccine (2013-2025)
1.5.1 United States Recombinant Vaccine Sales and Growth Rate (2013-2025)
1.5.2 United States Recombinant Vaccine Revenue and Growth Rate (2013-2025)
2 United States Recombinant Vaccine Market Competition by Players/Suppliers
2.1 United States Recombinant Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Recombinant Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Recombinant Vaccine Average Price by Players/Suppliers (2013-2018)
2.4 United States Recombinant Vaccine Market Competitive Situation and Trends
2.4.1 United States Recombinant Vaccine Market Concentration Rate
2.4.2 United States Recombinant Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Recombinant Vaccine Manufacturing Base Distribution, Sales Area, Product Type
3 United States Recombinant Vaccine Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Recombinant Vaccine Sales and Market Share by Region (2013-2018)
3.2 United States Recombinant Vaccine Revenue and Market Share by Region (2013-2018)
3.3 United States Recombinant Vaccine Price by Region (2013-2018)
4 United States Recombinant Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Recombinant Vaccine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Recombinant Vaccine Revenue and Market Share by Type (2013-2018)
4.3 United States Recombinant Vaccine Price by Type (2013-2018)
4.4 United States Recombinant Vaccine Sales Growth Rate by Type (2013-2018)
5 United States Recombinant Vaccine Sales (Volume) by Application (2013-2018)
5.1 United States Recombinant Vaccine Sales and Market Share by Application (2013-2018)
5.2 United States Recombinant Vaccine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Recombinant Vaccine Players/Suppliers Profiles and Sales Data
6.1 Merck & Co., Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Recombinant Vaccine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck & Co., Inc. Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Green Cross Corporation
6.2.2 Recombinant Vaccine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Green Cross Corporation Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Pfizer, Inc.
6.3.2 Recombinant Vaccine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer, Inc. Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Sanofi S A.
6.4.2 Recombinant Vaccine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi S A. Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Protein Science Corporation
6.5.2 Recombinant Vaccine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Protein Science Corporation Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline Plc
6.6.2 Recombinant Vaccine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 GlaxoSmithKline Plc Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Novartis AG
6.7.2 Recombinant Vaccine Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis AG Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Bharat Biotech
6.8.2 Recombinant Vaccine Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bharat Biotech Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
7 Recombinant Vaccine Manufacturing Cost Analysis
7.1 Recombinant Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Vaccine
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Recombinant Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Recombinant Vaccine Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Recombinant Vaccine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Recombinant Vaccine Sales Volume Forecast by Type (2018-2025)
11.3 United States Recombinant Vaccine Sales Volume Forecast by Application (2018-2025)
11.4 United States Recombinant Vaccine Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Recombinant Vaccine
Figure United States Recombinant Vaccine Market Size (K Doses) by Type (2013-2025)
Figure United States Recombinant Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Subunit Recombinant Vaccines Product Picture
Figure Attenuated Recombinant Vaccines Product Picture
Figure Vector Recombinant Vaccines Product Picture
Figure United States Recombinant Vaccine Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Recombinant Vaccine by Application in 2017
Figure Human Examples
Table Key Downstream Customer in Human
Figure Animal Examples
Table Key Downstream Customer in Animal
Figure United States Recombinant Vaccine Market Size (Million USD) by Region (2013-2025)
Figure The West Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Recombinant Vaccine Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Recombinant Vaccine Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Recombinant Vaccine Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Recombinant Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Recombinant Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Recombinant Vaccine Sales Share by Players/Suppliers
Figure United States Recombinant Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Recombinant Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Recombinant Vaccine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Recombinant Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Recombinant Vaccine Revenue Share by Players/Suppliers
Table United States Market Recombinant Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Recombinant Vaccine Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Recombinant Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Recombinant Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Recombinant Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Recombinant Vaccine Product Category
Table United States Recombinant Vaccine Sales (K Doses) by Region (2013-2018)
Table United States Recombinant Vaccine Sales Share by Region (2013-2018)
Figure United States Recombinant Vaccine Sales Share by Region (2013-2018)
Figure United States Recombinant Vaccine Sales Market Share by Region in 2017
Table United States Recombinant Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Recombinant Vaccine Revenue Share by Region (2013-2018)
Figure United States Recombinant Vaccine Revenue Market Share by Region (2013-2018)
Figure United States Recombinant Vaccine Revenue Market Share by Region in 2017
Table United States Recombinant Vaccine Price (USD/Dose) by Region (2013-2018)
Table United States Recombinant Vaccine Sales (K Doses) by Type (2013-2018)
Table United States Recombinant Vaccine Sales Share by Type (2013-2018)
Figure United States Recombinant Vaccine Sales Share by Type (2013-2018)
Figure United States Recombinant Vaccine Sales Market Share by Type in 2017
Table United States Recombinant Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Recombinant Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Recombinant Vaccine by Type (2013-2018)
Figure Revenue Market Share of Recombinant Vaccine by Type in 2017
Table United States Recombinant Vaccine Price (USD/Dose) by Types (2013-2018)
Figure United States Recombinant Vaccine Sales Growth Rate by Type (2013-2018)
Table United States Recombinant Vaccine Sales (K Doses) by Application (2013-2018)
Table United States Recombinant Vaccine Sales Market Share by Application (2013-2018)
Figure United States Recombinant Vaccine Sales Market Share by Application (2013-2018)
Figure United States Recombinant Vaccine Sales Market Share by Application in 2017
Table United States Recombinant Vaccine Sales Growth Rate by Application (2013-2018)
Figure United States Recombinant Vaccine Sales Growth Rate by Application (2013-2018)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Green Cross Corporation Basic Information List
Table Green Cross Corporation Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Sanofi S A. Basic Information List
Table Sanofi S A. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi S A. Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Sanofi S A. Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Sanofi S A. Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Protein Science Corporation Basic Information List
Table Protein Science Corporation Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novartis AG Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Novartis AG Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Novartis AG Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Bharat Biotech Basic Information List
Table Bharat Biotech Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bharat Biotech Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Bharat Biotech Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Bharat Biotech Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Vaccine
Figure Manufacturing Process Analysis of Recombinant Vaccine
Figure Recombinant Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Vaccine Major Players/Suppliers in 2017
Table Major Buyers of Recombinant Vaccine
Table Distributors/Traders List
Figure United States Recombinant Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Recombinant Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Recombinant Vaccine Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Type in 2025
Table United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Application in 2025
Table United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Recombinant Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Recombinant Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Recombinant Vaccine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
